리제네론

주관 임상 단계 분포

• 산업투자2026-07-15

  Attovia, Sanofi·Regeneron '듀피젠트' 대항마 개발 위해 IPO 신청

  Attovia Therapeutics가 기업공개(IPO)를 신청했다. 이번 IPO를 통해 조달한 자금은 파이프라인 자산 개발에 사용될 예정이다. 해당 자산 중에는 Sanofi와 Regeneron이 공동 개발한 '듀피젠트(Dupixent)' 및 Galderma의 '넴루비오(Nemluvio)'와 경쟁할 수 있는 후보물질이 포함된 것으로 전해졌다.

  Fierce Biotech ↗

FDA 승인

• 2023-08-18

  EYLEA HD

  AFLIBERCEPT

  BLA761355
• 2023-08-18

  VEOPOZ

  POZELIMAB-BBFG

  BLA761339

진행 중인 임상

• 2상모집 예정협력· Ebola Virus Disease

  Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers

  NCT05202288
• 2상모집 예정협력· Lung Cancer (NSCLC)

  Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

  NCT07450183
• 2상모집 예정협력· Glioblastoma

  Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas

  NCT07620548
• 1/2상모집 예정· High-Grade Glioma (HGG)

  A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma

  NCT07567469
• 3상모집 예정· Venous Thromboembolism (VTE)

  Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted Central Catheter (PICC)

  NCT07697599
• 단계 미표기모집 예정· Conjunctivitis Allergic

  A Study to Identify and Characterize Adults and Pediatric Participants With Cat and/or Birch Allergy

  NCT07710846
• 2상모집 중협력· Colon and Rectal Cancer

  Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)

  NCT07433673
• 2상모집 중협력· Non-small Cell Lung Cancer Stage III

  Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement

  NCT06449313
• 1/2상모집 예정협력· Ovarian Cancer

  Safety and Efficacy of Ubamatamab With First-line Chemotherapy in Ovarian Cancer

  NCT07637851
• 3상모집 예정· Atrial Fibrillation (AF)

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  NCT07626411
• 3상모집 예정· Fibrodysplasia Ossificans Progressiva (FOP)

  A Study to Investigate the Safety, Pharmacokinetics (PK), and Efficacy of Garetosmab in Children and Adolescents With Fibrodysplasia Ossificans Progressiva (FOP)

  NCT07559513
• 3상모집 중· Peripheral Artery Disease (PAD)

  Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

  NCT07318610
• 2상모집 예정· Overweight or Obesity

  Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

  NCT07685808
• 3상모집 예정· Allergic Conjunctivitis

  A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and Pediatric Participants With Allergic Conjunctivitis Due to Cat Allergy

  NCT07675811
• 1/2상모집 예정· Primary Open Angle Glaucoma (POAG)

  REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension

  NCT07675824
• 4상모집 예정· Relapsed/Refractory Multiple Myeloma (RRMM)

  Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

  NCT07609940
• 2상모집 예정· Metabolic Dysfunction-Associated Steatohepatitis (MASH)

  Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

  NCT07631637
• 1상모집 중· Prostate Cancer

  A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

  NCT07543055
• 1/2상모집 중협력· Rheumatoid Arthritis

  Phase 1b/2 Study of IV Sarilumab in Adult With RA

  NCT07704580
• 1상모집 예정협력· Hepatocellular Carcinoma

  Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma

  NCT07365839